Dihydroergotamine mesylate bulk supplier for pharma manufacturers

Dihydroergotamine Mesylate 4 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Nasal Spray

Available Strengths: 4 mg/mL

Reference Brands: Migranal (USA/EU)

Category: Neurology

Dihydroergotamine is an ergot alkaloid used to treat acute migraine attacks and cluster headaches. It works by constricting blood vessels in the brain and reducing inflammation around cranial nerves, which helps relieve migraine symptoms.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Dihydroergotamine Mesylate — third party manufacturing & bulk supply

Dihydroergotamine Mesylate 4 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dihydroergotamine Mesylate is supplied as Nasal Spray — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dihydroergotamine Mesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dihydroergotamine Mesylate →

Back to Listing

Frequently Asked Questions

Dihydroergotamine mesylate is listed as Nasal Spray in 4 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Dihydroergotamine mesylate is referenced against Migranal (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.